prikaz prve stranice dokumenta Type 2 diabetes and viral infection; cause and effect of disease
  Preuzmi
PDF 1.02 MB
Znanstveni rad - Pregledni rad
Type 2 diabetes and viral infection; cause and effect of disease
Diabetes Research and Clinical Practice, 172 (2021); 108637. https://doi.org/10.1016/j.diabres.2020.108637
Turk Wensveen, Tamara; Gašparini, Dora; Rahelić, Dario; Wensveen, Felix M.

Povezani objekti
COVID-19 | Virtualna zbirka
Citirajte ovaj rad

Turk Wensveen, T., Gašparini, D., Rahelić, D. i Wensveen, F. M. (2021). Type 2 diabetes and viral infection; cause and effect of disease. Diabetes Research and Clinical Practice, 172.. doi: 10.1016/j.diabres.2020.108637

Turk Wensveen, Tamara, et al. "Type 2 diabetes and viral infection; cause and effect of disease." Diabetes Research and Clinical Practice, vol. 172, 2021. https://doi.org/10.1016/j.diabres.2020.108637

Turk Wensveen, Tamara, Dora Gašparini, Dario Rahelić i Felix M. Wensveen. "Type 2 diabetes and viral infection; cause and effect of disease." Diabetes Research and Clinical Practice 172 (2021). https://doi.org/10.1016/j.diabres.2020.108637

Turk Wensveen, T., et al. (2021) 'Type 2 diabetes and viral infection; cause and effect of disease', Diabetes Research and Clinical Practice, 172. doi: 10.1016/j.diabres.2020.108637

Turk Wensveen T, Gašparini D, Rahelić D, Wensveen FM. Type 2 diabetes and viral infection; cause and effect of disease. Diabetes Research and Clinical Practice [Internet]. 02.2021. [pristupljeno 24.12.2024.];172. doi: 10.1016/j.diabres.2020.108637

T. Turk Wensveen, D. Gašparini, D. Rahelić i F. M. Wensveen, "Type 2 diabetes and viral infection; cause and effect of disease", Diabetes Research and Clinical Practice, vol. 172, Veljača 2021. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:548244. [Citirano: 24.12.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:184:548244
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Type 2 diabetes and viral infection; cause and effect of disease
AutorTamara Turk Wensveen
AutorDora Gašparini https://orcid.org/0000-0002-0503-9516
AutorDario Rahelić
AutorFelix M. Wensveen
Autorova ustanovaSveučilište u Rijeci
Medicinski fakultet
(Katedra za histologiju i embriologiju)
Autorova ustanovaSveučilište u Rijeci
Medicinski fakultet
(Katedra za internu medicinu)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Temeljne medicinske znanosti
Imunologija
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Interna medicina
Sažetak (engleski)
The recent pandemic of COVID-19 has made abundantly clear that Type 2 diabetes (T2D) increases the risk of more frequent and more severe viral infections. At the same time, pro-inflammatory cytokines of an anti-viral Type-I profile promote insulin resistance and form a risk factor for development of T2D. What this illustrates is that there is a reciprocal, detrimental interaction between the immune and endocrine system in the context of T2D. Why these two systems would interact at all long remained unclear. Recent findings indicate that transient changes in systemic metabolism are induced by the immune system as a strategy against viral infection. In people with T2D, this system fails, thereby negatively impacting the antiviral immune response. In addition, immune-mediated changes in systemic metabolism upon infection may aggravate glycemic control in T2D. In this review, we will discuss recent literature that sheds more light on how T2D impairs immune responses to viral infection and how virus-induced activation of the immune system increases risk of development of T2D.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Pregledni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran - međunarodna recenzija
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaDiabetes Research and Clinical Practice
Brojčani podacivol. 172, 108637
p-ISSN0168-8227
DOIhttps://doi.org/10.1016/j.diabres.2020.108637
URN:NBNurn:nbn:hr:184:548244
Datum objave publikacije2021-02
ProjektŠifra: IP-2016-06-8027
Naziv (hrvatski): Preuređivanje memorije: Manipuliranje T-staničnom memorijom u svrhu unapređenja učinkovitosti cjepiva
Kratica: T-MEMORY
Voditelj: Felix Wensveen
Pravna nadležnost: Hrvatska
Financijer: HRZZ
Linija financiranja: IP
ProjektŠifra: IP-CORONA-2020-04-2045
Naziv (hrvatski): Manipuliranje imunološkom memorijom: razvoj novih strategija u svrhu stvaranja boljeg memorijskog CD8 T-staničnog odgovora protiv COVID-19 nakon cijepljenja
Voditelj: Felix Martinus Wensveen
Pravna nadležnost: Hrvatska
Financijer: HRZZ
Linija financiranja: IP-CORONA
URL dokumentahttps://linkinghub.elsevier.com/retrieve/pii/S0168822720308949
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Imenovanje-Nekomercijalno-Bez prerada 4.0 međunarodna (CC BY-NC-ND 4.0)
Datum i vrijeme pohrane2021-04-19 11:20:53